Loading
Longevity Health Holdings, Inc. Stock: price and insider trades · United States
US·Mcap US$274.8k
No insider purchase over the last 90 days. The latest, by Ajjarapu J. Ram, was filed 08 Apr 2026.
Longevity Health Holdings, Inc.: what insiders have been doing
Every trade that managers of Longevity Health Holdings, Inc. disclose to SEC (Form 4) is tracked on this page. The last twelve months, up to 18 October 2026, brought 1 filing signed by 1 insider.
Every open-market trade in the period is a purchase: 1 purchase worth €175k, from 1 insider, and not a single sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. On the buying side, the filings list 1 chief executive among the declarants. At €175k, the purchase published on 8 April 2026 by Ajjarapu J. Ram is the largest of the period.
With 1 filing in twelve months, the company is quieter than the median of 22 filings across the 5,458 companies we follow on the same exchange. Our records for Longevity Health Holdings, Inc. go back to 2021, with 50 purchases and no sales on the open market in total.
The last insider purchase was made public on 8 April 2026, 193 days ago.
Elsewhere in the same market, our signals recently picked up insider purchases at GameStop Corp. and Heico Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
66
Thresholds
n/a
Buy Volume
€301,750
50 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleJ. Ram Ajjarapu1 buy
Since the insiders bought
- -28.5%Entry US$0.32 · Close at T+90 US$0.23
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.11
Analyst consensus
Income statement
RevenueUS$1.9M
Gross profitUS$1.1M57% margin
EBITDA-US$6.6M-347% margin
Net income-US$6.9M-361.0% margin
Valuation
Beta0.43
Balance sheet & cash
Market capUS$274.8k
Total debtUS$499.9k
Free Cash Flow-US$3.3M
Profitability & ownership
ROA-158.9%
% insiders36.1%
% institutions0.8%
Last declaration on 8 April 2026
Declarations66 total
689,656 shares@ US$0.29100.0% of flowCommon StockSEC:0001193125-26-148078:0
Canonical exit: 14 Jun 2026 (T+90)
5,000 shares@ US$0.467213.5% of flowCommon StockSEC:0000950170-24-106857:0
Canonical exit: 12 Dec 2024 (T+90)
1,261 shares@ US$0.515.2% of flowCommon StockSEC:0000950170-24-105168:0
Canonical exit: 5 Dec 2024 (T+90)
1,009 shares@ US$0.516.5% of flowCommon StockSEC:0000950170-24-105167:0
Canonical exit: 5 Dec 2024 (T+90)
475 shares@ US$0.462.8% of flowCommon StockSEC:0000950170-24-105166:0
Canonical exit: 9 Dec 2024 (T+90)
1,009 shares@ US$0.516.5% of flowCommon StockSEC:0000950170-24-105170:0
Canonical exit: 5 Dec 2024 (T+90)
1,260 shares@ US$0.514.1% of flowCommon StockSEC:0000950170-24-105169:0
Canonical exit: 5 Dec 2024 (T+90)
109 shares@ US$0.570.5% of flowCommon StockSEC:0000950170-24-103449:0
Canonical exit: 28 Nov 2024 (T+90)
87 shares@ US$0.570.6% of flowCommon StockSEC:0000950170-24-103448:0
Canonical exit: 28 Nov 2024 (T+90)
87 shares@ US$0.570.6% of flowCommon StockSEC:0000950170-24-103471:0
Canonical exit: 28 Nov 2024 (T+90)
109 shares@ US$0.570.4% of flowCommon StockSEC:0000950170-24-103547:0
Canonical exit: 28 Nov 2024 (T+90)
970 shares@ US$0.564.4% of flowCommon StockSEC:0000950170-24-102374:0
Canonical exit: 26 Nov 2024 (T+90)
1,000 shares@ US$0.577.2% of flowCommon StockSEC:0000950170-24-102370:0
Canonical exit: 27 Nov 2024 (T+90)
1,084 shares@ US$0.563.8% of flowCommon StockSEC:0000950170-24-102373:0
Canonical exit: 26 Nov 2024 (T+90)
749 shares@ US$0.564.6% of flowCommon StockSEC:0000950170-24-102369:0
Canonical exit: 26 Nov 2024 (T+90)
599 shares@ US$0.564.3% of flowCommon StockSEC:0000950170-24-102371:0
Canonical exit: 26 Nov 2024 (T+90)
599 shares@ US$0.564.3% of flowCommon StockSEC:0000950170-24-102372:0
Canonical exit: 26 Nov 2024 (T+90)
1,587 shares@ US$0.719.0% of flowCommon StockSEC:0000950170-24-101944:0
Canonical exit: 25 Nov 2024 (T+90)
2,413 shares@ US$0.7110.7% of flowCommon StockSEC:0000950170-24-101949:0
Canonical exit: 25 Nov 2024 (T+90)
1,587 shares@ US$0.729.2% of flowCommon StockSEC:0000950170-24-100725:0
Canonical exit: 21 Nov 2024 (T+90)
2,413 shares@ US$0.7211.0% of flowCommon StockSEC:0000950170-24-100723:0
Canonical exit: 21 Nov 2024 (T+90)
3,016 shares@ US$0.79215.0% of flowCommon StockSEC:0000950170-24-100251:0
Canonical exit: 19 Nov 2024 (T+90)
1,984 shares@ US$0.07921.3% of flowCommon StockSEC:0000950170-24-100267:0
Canonical exit: 19 Nov 2024 (T+90)
3,600 shares@ US$0.89418.6% of flowCommon StockSEC:0000950170-24-099586:0
Canonical exit: 18 Nov 2024 (T+90)
2,000 shares@ US$2.204626.2% of flowCommon StockSEC:0000950170-24-073349:0
Canonical exit: 10 Sept 2024 (T+90)
25 of 66 declarations
About Longevity Health Holdings, Inc.
Longevity Health Holdings, Inc. is a NASDAQ-listed company focused on developing health solutions aimed at aging. The company emphasizes innovation in the healthcare sector to enhance the quality of life for elderly individuals.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
